NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 82 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2014. The put-call ratio across all filers is 179.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $0 | – | 3 | -87.0% | 0.00% | – |
| Q4 2017 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 23 | -100.0% | 0.00% | – |
| Q3 2016 | $199,000 | -15.0% | 217,462 | -50.6% | 0.00% | – |
| Q2 2016 | $234,000 | – | 439,989 | +5080.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 8,494 | -60.4% | 0.00% | – |
| Q4 2015 | $22,000 | -82.4% | 21,436 | -65.4% | 0.00% | – |
| Q3 2015 | $125,000 | +525.0% | 61,960 | +222.7% | 0.00% | – |
| Q2 2015 | $20,000 | 0.0% | 19,198 | +1.3% | 0.00% | – |
| Q1 2015 | $20,000 | -70.6% | 18,947 | -72.2% | 0.00% | – |
| Q4 2014 | $68,000 | +30.8% | 68,188 | +31.2% | 0.00% | – |
| Q3 2014 | $52,000 | -44.1% | 51,980 | -44.2% | 0.00% | – |
| Q2 2014 | $93,000 | 0.0% | 93,175 | -0.4% | 0.00% | – |
| Q1 2014 | $93,000 | -46.9% | 93,532 | +6.5% | 0.00% | – |
| Q4 2013 | $175,000 | +19.0% | 87,788 | +19.6% | 0.00% | – |
| Q3 2013 | $147,000 | -43.0% | 73,391 | -24.1% | 0.00% | – |
| Q2 2013 | $258,000 | – | 96,686 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|